豚インフルエンザワクチンの世界市場レポート 2025

豚インフルエンザワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で201億5,000万米ドルに成長します。予測期間の成長は、筋肉内ワクチンの需要拡大、ワクチン接種における新技術の認知度向上、高齢者人口の増加、国民の健康を守るためのワクチン接種の必要性、疾病発生率の増加、h1n1感染による世界的大流行のエピソードなどに起因すると考えられます。予測期間における主な動向としては、技術の進歩、事業の拡大、製品の発売、戦略的合併・買収、製薬企業間の提携などが挙げられます。

ワクチン接種プログラムを目的とした政府のイニシアチブは、今後の豚インフルエンザワクチン市場の成長を促進すると予想されます。こうした取り組みには、予防接種の取り組みを促進・支援するために政府が実施する行動や政策が含まれます。豚インフルエンザワクチンは、必要なワクチンと資源を確保することで予防接種キャンペーンを優先し、効果的にアウトブレイクを管理することで、公衆衛生イニシアチブを強化するよう政府に働きかけています。例えば、2024年9月、米国を拠点とし、感染症の蔓延防止を担当する国家保健機関である疾病対策予防センター（CDC）からの報告によると、2023-24年のインフルエンザ・シーズン中に、生後6ヵ月から17歳までの子どもの55.4％が少なくとも1回のインフルエンザ・ワクチンの接種を受けたことが明らかになりました。さらに政府は、供給途絶に備えた備蓄のため、成人用インフルエンザワクチン930万回分を割り当てた。その結果、ワクチン接種プログラムに対する政府支援の高まりが、豚インフルエンザワクチン市場の拡大に拍車をかけています。

豚インフルエンザワクチン市場の主なプレーヤーは、市場での地位を強化するために、4価インフルエンザワクチンなどの革新的な製品の開発に注力しています。4価インフルエンザ・ワクチンは、4つの異なるインフルエンザ・ウイルス株を防御するように設計されており、従来のワクチンと比較して防御力が強化されています。例えば、カディラ・ファーマシューティカルズは2024年3月、4種類のインフルエンザ・ウイルスA型とB型を標的とした最先端の4価インフルエンザ・ワクチン、カディフル・テトラを発売しました。ナノサイズの粒子技術を活用したカディフルテトラは、ウイルスの外部構造を模倣し、そのままの遺伝物質を含まずに有効性と安全性を高めています。この高度なアプローチにより、複数のインフルエンザ株に対する予防効果が向上し、季節性流行を予防するための技術的に優れたソリューションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界豚インフルエンザワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の豚インフルエンザワクチン市場：成長率分析
• 世界の豚インフルエンザワクチン市場の実績：規模と成長, 2019-2024
• 世界の豚インフルエンザワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界豚インフルエンザワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の豚インフルエンザワクチン市場ワクチンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻腔内
• トキソイド
• 共役
• 不活化ワクチン
• 弱毒化ワクチン
• その他のワクチンの種類
• 世界の豚インフルエンザワクチン市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インフルエンザ
• 髄膜炎菌
• 子宮頸がん
• 肺炎球菌
• 肝炎
• 麻疹
• おたふく風邪
• 風疹
• 世界の豚インフルエンザワクチン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界の豚インフルエンザワクチン市場、鼻腔内タイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化経鼻ワクチン
• 不活化経鼻ワクチン
• 世界の豚インフルエンザワクチン市場、トキソイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ホルムアルデヒド不活化トキソイドワクチン
• 世界の豚インフルエンザワクチン市場、共役のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タンパク質結合ワクチン
• 世界の豚インフルエンザワクチン市場不活化ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射用不活化ワクチン
• 不活化サブユニットワクチン
• 世界の豚インフルエンザワクチン市場弱毒化ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化インフルエンザワクチン
• 世界の豚インフルエンザワクチン市場、その他のワクチンタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAワクチン
• 組み換えワクチン

第7章 地域別・国別分析

• 世界の豚インフルエンザワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の豚インフルエンザワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 豚インフルエンザワクチン市場：競合情勢
• 豚インフルエンザワクチン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Mylan N.V.
• Moderna Inc.
• Baxter International Inc.
• Zoetis Inc.
• Elanco Animal Health
• Cipla Inc.
• Lupin Ltd.
• Virbac S.A
• Sinovac Biotech Ltd.
• Serum Institute of India Private Limited.
• Vetoquinol S.A

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 豚インフルエンザワクチン市場2029：新たな機会を提供する国
• 豚インフルエンザワクチン市場2029：新たな機会を提供するセグメント
• 豚インフルエンザワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Swine flu vaccination refers to vaccines formulated to safeguard against influenza viruses commonly found in pigs (swine flu). These vaccines are developed with the aim of preventing the transmission of swine flu from pigs to humans.

Within the swine flu vaccination market, the primary vaccine types include intranasal, toxoid, conjugate, inactivated vaccine, attenuated vaccine, and others. An intranasal vaccine is administered through the nasal passages, stimulating the immune system to guard against specific diseases by introducing weakened or deactivated pathogens. Various treatment types encompass influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, and others. These treatments are utilized across a spectrum of end-users, including hospitals, clinics, and other healthcare facilities.

The swine flu vaccination market research report is one of a series of new reports from The Business Research Company that provides swine flu vaccination market statistics, including swine flu vaccination industry global market size, regional shares, competitors with a swine flu vaccination market share, detailed swine flu vaccination market segments, market trends, and opportunities, and any further data you may need to thrive in the swine flu vaccination industry. This swine flu vaccination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The swine flu vaccination market size has grown strongly in recent years. It will grow from $13.99 billion in 2024 to $15.09 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to the increasing prevalence of flu, declining immunity among the geriatric population, increasing incidence of swine flu cases, government initiatives towards immunization programs, and advancements in vaccine production and distribution.

The swine flu vaccination market size is expected to see strong growth in the next few years. It will grow to $20.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for intramuscular vaccines, increasing awareness of new technologies in vaccination, increasing rate of elderly population, the need for vaccinations to protect the public's health, increased incidence of disease and episodes of pandemic worldwide from h1n1 infection. Major trends in the forecast period include technological advancement, business expansions, product launches, strategic mergers and acquisitions, and partnerships among pharmaceutical firms.

Government initiatives aimed at vaccination programs are expected to drive the growth of the swine flu vaccination market in the future. These initiatives involve actions and policies implemented by governments to promote and support vaccination efforts. The swine flu vaccination encourages governments to prioritize immunization campaigns by ensuring the availability of necessary vaccines and resources to effectively manage outbreaks, thereby strengthening public health initiatives. For example, in September 2024, reports from the Centers for Disease Control and Prevention (CDC), a US-based national health agency responsible for controlling the spread of infectious diseases, revealed that 55.4% of children aged 6 months to 17 years received at least one dose of the flu vaccine during the 2023-24 flu season. Furthermore, the government allocated 9.3 million doses of the adult influenza vaccine to create a stockpile in case of supply disruptions. As a result, the growing government support for vaccination programs is fueling the expansion of the swine flu vaccination market.

Key players in the swine flu vaccination market are concentrating on developing innovative products such as the quadrivalent influenza vaccine to strengthen their market position. The quadrivalent influenza vaccine is designed to protect against four different influenza virus strains, offering enhanced protection compared to traditional vaccines. For instance, in March 2024, Cadila Pharmaceuticals launched Cadiflu Tetra, a cutting-edge quadrivalent influenza vaccine targeting four influenza virus subtypes A and B strains. Utilizing nano-sized particle technology, Cadiflu Tetra mimics the virus's external structure, enhancing efficacy and safety without containing intact genetic material. This advanced approach provides improved protection against multiple influenza strains, offering a technologically superior solution for preventing seasonal epidemics.

In September 2024, Alopexx, Inc., a US-based clinical-stage biotechnology company, entered into a partnership with Bharat Biotech. This collaboration aims to jointly develop and commercialize Alopexx's broad-spectrum antimicrobial vaccine, AV0328, to tackle critical infectious disease challenges in low- and middle-income countries, while helping combat antimicrobial resistance. The partnership leverages Bharat Biotech's expertise in vaccine development and Alopexx's innovative technology to ensure affordable, high-quality vaccines are made widely available. Bharat Biotech, an India-based manufacturer, is known for its swine flu vaccines.

Major companies operating in the swine flu vaccination market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Mylan N.V., Moderna Inc., Baxter International Inc., Zoetis Inc., Elanco Animal Health, Cipla Inc., Lupin Ltd., Virbac S.A, Sinovac Biotech Ltd., Serum Institute of India Private Limited., Vetoquinol S.A, IDT Biologika GmbH, Bharat Biotech International Limited, Medicago Inc., Panacea Biotec, Hipra.

North America was the largest region in the swine flu vaccination market in 2024. The regions covered in the swine flu vaccination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the swine flu vaccination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The swine flu vaccination market includes revenues earned by entities by vaccine administration, assessment and screening, documentation and record-keeping, and follow-up and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The swine flu vaccination market consists of sales of fluMist quadrivalent, FluLaval quadrivalent, Fluzone quadrivalent, and afluria quadrivalent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Swine Flu Vaccination Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on swine flu vaccination market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for swine flu vaccination ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The swine flu vaccination market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Vaccine Type: Intranasal; Toxoid; Conjugate; Inactivated Vaccine; Attenuated Vaccine; Other Vaccine Type
• 2) By Treatment Type: Influenza; Meningococcal; Cervical Cancer; Pneumococcal; Hepatitis; Measles; Mumps; Rubella
• 3) By End User: Hospital; Clinic; Other End User
• 1) By Intranasal: Live Attenuated Intranasal Vaccines; Inactivated Intranasal Vaccines
• 2) By Toxoid: Formaldehyde-Inactivated Toxoid Vaccines
• 3) By Conjugate: Protein Conjugate Vaccines
• 4) By Inactivated Vaccine: Injectable Inactivated Vaccines; Inactivated Subunit Vaccines
• 5) By Attenuated Vaccine: Live Attenuated Influenza Vaccines
• 6) By Other Vaccine Type: DNA Vaccines; Recombinant Vaccines
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Swine Flu Vaccination Market Characteristics

3. Swine Flu Vaccination Market Trends And Strategies

4. Swine Flu Vaccination Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Swine Flu Vaccination Growth Analysis And Strategic Analysis Framework

• 5.1. Global Swine Flu Vaccination PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Swine Flu Vaccination Market Growth Rate Analysis
• 5.4. Global Swine Flu Vaccination Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Swine Flu Vaccination Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Swine Flu Vaccination Total Addressable Market (TAM)

6. Swine Flu Vaccination Market Segmentation

• 6.1. Global Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intranasal
• Toxoid
• Conjugate
• Inactivated Vaccine
• Attenuated Vaccine
• Other Vaccine Type
• 6.2. Global Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Influenza
• Meningococcal
• Cervical Cancer
• Pneumococcal
• Hepatitis
• Measles
• Mumps
• Rubella
• 6.3. Global Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinic
• Other End User
• 6.4. Global Swine Flu Vaccination Market, Sub-Segmentation Of Intranasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Intranasal Vaccines
• Inactivated Intranasal Vaccines
• 6.5. Global Swine Flu Vaccination Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Formaldehyde-Inactivated Toxoid Vaccines
• 6.6. Global Swine Flu Vaccination Market, Sub-Segmentation Of Conjugate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Conjugate Vaccines
• 6.7. Global Swine Flu Vaccination Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Inactivated Vaccines
• Inactivated Subunit Vaccines
• 6.8. Global Swine Flu Vaccination Market, Sub-Segmentation Of Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Influenza Vaccines
• 6.9. Global Swine Flu Vaccination Market, Sub-Segmentation Of Other Vaccine Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Vaccines
• Recombinant Vaccines

7. Swine Flu Vaccination Market Regional And Country Analysis

• 7.1. Global Swine Flu Vaccination Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Swine Flu Vaccination Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Swine Flu Vaccination Market

• 8.1. Asia-Pacific Swine Flu Vaccination Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Swine Flu Vaccination Market

• 9.1. China Swine Flu Vaccination Market Overview
• 9.2. China Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Swine Flu Vaccination Market

• 10.1. India Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Swine Flu Vaccination Market

• 11.1. Japan Swine Flu Vaccination Market Overview
• 11.2. Japan Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Swine Flu Vaccination Market

• 12.1. Australia Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Swine Flu Vaccination Market

• 13.1. Indonesia Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Swine Flu Vaccination Market

• 14.1. South Korea Swine Flu Vaccination Market Overview
• 14.2. South Korea Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Swine Flu Vaccination Market

• 15.1. Western Europe Swine Flu Vaccination Market Overview
• 15.2. Western Europe Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Swine Flu Vaccination Market

• 16.1. UK Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Swine Flu Vaccination Market

• 17.1. Germany Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Swine Flu Vaccination Market

• 18.1. France Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Swine Flu Vaccination Market

• 19.1. Italy Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Swine Flu Vaccination Market

• 20.1. Spain Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Swine Flu Vaccination Market

• 21.1. Eastern Europe Swine Flu Vaccination Market Overview
• 21.2. Eastern Europe Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Swine Flu Vaccination Market

• 22.1. Russia Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Swine Flu Vaccination Market

• 23.1. North America Swine Flu Vaccination Market Overview
• 23.2. North America Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Swine Flu Vaccination Market

• 24.1. USA Swine Flu Vaccination Market Overview
• 24.2. USA Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Swine Flu Vaccination Market

• 25.1. Canada Swine Flu Vaccination Market Overview
• 25.2. Canada Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Swine Flu Vaccination Market

• 26.1. South America Swine Flu Vaccination Market Overview
• 26.2. South America Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Swine Flu Vaccination Market

• 27.1. Brazil Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Swine Flu Vaccination Market

• 28.1. Middle East Swine Flu Vaccination Market Overview
• 28.2. Middle East Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Swine Flu Vaccination Market

• 29.1. Africa Swine Flu Vaccination Market Overview
• 29.2. Africa Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Swine Flu Vaccination Market Competitive Landscape And Company Profiles

• 30.1. Swine Flu Vaccination Market Competitive Landscape
• 30.2. Swine Flu Vaccination Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Swine Flu Vaccination Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Boehringer Ingelheim International GmbH
• 31.5. Mylan N.V.
• 31.6. Moderna Inc.
• 31.7. Baxter International Inc.
• 31.8. Zoetis Inc.
• 31.9. Elanco Animal Health
• 31.10. Cipla Inc.
• 31.11. Lupin Ltd.
• 31.12. Virbac S.A
• 31.13. Sinovac Biotech Ltd.
• 31.14. Serum Institute of India Private Limited.
• 31.15. Vetoquinol S.A

32. Global Swine Flu Vaccination Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Swine Flu Vaccination Market

34. Recent Developments In The Swine Flu Vaccination Market

35. Swine Flu Vaccination Market High Potential Countries, Segments and Strategies

• 35.1 Swine Flu Vaccination Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Swine Flu Vaccination Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Swine Flu Vaccination Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer